RVL Pharmaceuticals plc

OTCPK:RVLP.Q Stok Raporu

Piyasa değeri: US$111.0

RVL Pharmaceuticals Yönetim

Yönetim kriter kontrolleri 3/4

RVL Pharmaceuticals CEO'su Brian Markison, Jan2016 tarihinde atandı, in görev süresi 8.83 yıldır. şirketin hisselerinin 2.1% doğrudan sahiptir ve bu hisselerin değeri $ 2.33 dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 8.8 yıl ve 5.5 yıldır.

Anahtar bilgiler

Brian Markison

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi8.8yrs
CEO sahipliği2.1%
Yönetim ortalama görev süresi8.8yrs
Yönetim Kurulu ortalama görev süresi5.5yrs

Son yönetim güncellemeleri

Recent updates

RVL Pharmaceuticals plc (NASDAQ:RVLP) Analysts Just Cut Their EPS Forecasts Substantially

Aug 16
RVL Pharmaceuticals plc (NASDAQ:RVLP) Analysts Just Cut Their EPS Forecasts Substantially

Analysts Just Made A Major Revision To Their RVL Pharmaceuticals plc (NASDAQ:RVLP) Revenue Forecasts

May 13
Analysts Just Made A Major Revision To Their RVL Pharmaceuticals plc (NASDAQ:RVLP) Revenue Forecasts

RVL Pharmaceuticals plc (NASDAQ:RVLP) Doing What It Can To Lift Shares

May 12
RVL Pharmaceuticals plc (NASDAQ:RVLP) Doing What It Can To Lift Shares

RVL Pharmaceuticals (NASDAQ:RVLP) Is Making Moderate Use Of Debt

Apr 20
RVL Pharmaceuticals (NASDAQ:RVLP) Is Making Moderate Use Of Debt

Is RVL Pharmaceuticals (NASDAQ:RVLP) Using Debt Sensibly?

Jan 05
Is RVL Pharmaceuticals (NASDAQ:RVLP) Using Debt Sensibly?

RVL Pharmaceuticals sees Q3 net sales of UPNEEQ for eye treatment about $10M

Oct 18

RVL Pharmaceuticals: Chapter 2 - A Developing Quandary

Sep 22

RVL Pharma in pact with Revision Skincare to broaden access to products

Aug 30

GAAP EPS of -$0.14 beats by $0.07, revenue of $8.45M misses by $0.07M

Aug 11

RVL Pharma posts preliminary 42% sales growth for eye treatment

Jul 07

RVL Pharmaceuticals (NASDAQ:RVLP) Is Carrying A Fair Bit Of Debt

Jul 04
RVL Pharmaceuticals (NASDAQ:RVLP) Is Carrying A Fair Bit Of Debt

RVL Pharmaceuticals: Chapter 1 Gives A Mixed Picture

Jun 15

New Forecasts: Here's What Analysts Think The Future Holds For RVL Pharmaceuticals plc (NASDAQ:RVLP)

Apr 01
New Forecasts: Here's What Analysts Think The Future Holds For RVL Pharmaceuticals plc (NASDAQ:RVLP)

RVL Pharmaceuticals: A Makeover For An Ugly Duckling

Mar 30

Osmotica: A Different Breed Of Cat

Dec 14

Osmotica Pharmaceuticals (NASDAQ:OSMT) Takes On Some Risk With Its Use Of Debt

Aug 20
Osmotica Pharmaceuticals (NASDAQ:OSMT) Takes On Some Risk With Its Use Of Debt

Osmotica: Paring Down, Focusing On UPNEEQ

Jul 16

CEO Tazminat Analizi

Brian Markison'un ücretlendirmesi RVL Pharmaceuticals'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2023n/an/a

-US$68m

Mar 31 2023n/an/a

-US$56m

Dec 31 2022US$525kUS$525k

-US$52m

Sep 30 2022n/an/a

-US$53m

Jun 30 2022n/an/a

-US$66m

Mar 31 2022n/an/a

-US$76m

Dec 31 2021US$1mUS$665k

-US$83m

Sep 30 2021n/an/a

-US$115m

Jun 30 2021n/an/a

-US$86m

Mar 31 2021n/an/a

-US$82m

Dec 31 2020US$4mUS$716k

-US$89m

Sep 30 2020n/an/a

-US$64m

Jun 30 2020n/an/a

-US$178m

Mar 31 2020n/an/a

-US$285m

Dec 31 2019US$4mUS$683k

-US$271m

Sep 30 2019n/an/a

-US$351m

Jun 30 2019n/an/a

-US$243m

Mar 31 2019n/an/a

-US$112m

Dec 31 2018US$1mUS$633k

-US$110m

Sep 30 2018n/an/a

-US$1m

Jun 30 2018n/an/a

-US$10m

Mar 31 2018n/an/a

-US$31m

Dec 31 2017US$1mUS$613k

-US$41m

Tazminat ve Piyasa: Brian şirketinin toplam tazminatının US pazarındaki benzer büyüklükteki şirketlerle karşılaştırıldığında makul olup olmadığını tespit etmek için yeterli veri yok.

Tazminat ve Kazançlar: Brian 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Brian Markison (65 yo)

8.8yrs

Görev süresi

US$525,000

Tazminat

Mr. Brian A. Markison has served as Chairman of the Board and Chief Executive Officer of Osmotica Pharmaceutical Corp. since 2016. Mr. Markison had been an Operating Executive and Healthcare Industry Execu...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Brian Markison
Chairman8.8yrsUS$525.00k2.1%
$ 2.3
James Schaub
Executive VP & COO8.8yrsUS$367.20k0.45%
$ 0.5
Christopher Klein
General Counsel10.9yrsUS$367.20k0.15%
$ 0.2
Michael DePetris
Principal Accounting Officer2.6yrsVeri yokVeri yok
Jarret Miller
Executive Vice President of Human Resources8.8yrsVeri yokVeri yok
Scott Schroppe
Secretaryno dataVeri yokVeri yok

8.8yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim: RVLP.Q 'un yönetim ekibi deneyimli ve deneyimlidir ( 8.8 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Brian Markison
Chairman8.8yrsUS$525.00k2.1%
$ 2.3
Gregory Cowan
Independent Director5.8yrsUS$234.00k0.045%
$ 0.05
Alisa Lask
Independent Director2.3yrsUS$159.94k0.020%
$ 0.02
Michael DeBiasi
Independent Director5.1yrsUS$309.10kVeri yok

5.5yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: RVLP.Q 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.5 yıldır).